Boehringer And Anthem Put Stiolto Duo To Real World Test In COPD
Executive Summary
US noninferiority study mainly of Anthem beneficiaries aims to show if COPD patients are being overtreated with LABA/LAMA/ICS triple combos when a LABA/LAMA duo would do.